French pharmaceutical company Sanofi said on Wednesday that it is ready to offer the French authorities the anti-malarial drug in the fight against the new coronavirus killing thousands worldwide.

In a recent clinical trial, the Plaquenil drug was tested on 24 patients, and after six days, the virus had disappeared in three quarters of them.

The trial was carried out by Professor Didier Raoult, director of IHU Mediterranee Infection, a research institute based in Marseille.

Sanofi said they are in possession of several million doses, enough to treat 300,000 people infected with COVID-19.

“Sanofi is committed to making its

Read more: France: Sanofi offers potential drug to beat COVID-19